Correlation Between Pharmala Biotech and Regenicin

Can any of the company-specific risk be diversified away by investing in both Pharmala Biotech and Regenicin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmala Biotech and Regenicin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmala Biotech Holdings and Regenicin, you can compare the effects of market volatilities on Pharmala Biotech and Regenicin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmala Biotech with a short position of Regenicin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmala Biotech and Regenicin.

Diversification Opportunities for Pharmala Biotech and Regenicin

0.0

Correlation Coefficient

Pharmala Biotech  Regenicin

Pay attention - limited upside

The 3 months correlation between Pharmala and Regenicin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmala Biotech Holdings and Regenicin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenicin and Pharmala Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmala Biotech Holdings are associated (or correlated) with Regenicin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenicin has no effect on the direction of Pharmala Biotech i.e., Pharmala Biotech and Regenicin go up and down completely randomly.

Pair Corralation between Pharmala Biotech and Regenicin

If you would invest  0.01  in Regenicin on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Regenicin or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Pharmala Biotech Holdings  vs.  Regenicin

Pharmala Biotech Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Regenicin

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regenicin has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Regenicin is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Pharmala Biotech and Regenicin

The main advantage of trading using opposite Pharmala Biotech and Regenicin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmala Biotech position performs unexpectedly, Regenicin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will offset losses from the drop in Regenicin's long position.

The idea behind Pharmala Biotech Holdings and Regenicin pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.